Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 12%
Buy 35%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

Inspire Medical Systems is a promising company with a unique neurostimulation technology that provides a safe and effective treatment for obstructive sleep apnea. The company has recently commercialized its Inspire V system, which eliminates the need for a pressure sensing lead, and has a strong strategy in place to increase sales and awareness of its product. Challenges such as reimbursement changes and potential competition in the market may impact the company's growth in the near term, but the long-term potential and a large total addressable market make this a solid investment opportunity.

Bears say

Inspire Medical Systems is facing challenges in the evolving reimbursement landscape and has lowered its 2026 revenue guidance by 4-10% due to uncertainty around coding and physician reimbursement rates. There is a risk that the RUC process could result in a lower overall payment for a new CPT code, and the company's reliance on the existing code may lead to potential frictions with payers. While the company maintains a positive outlook on its operating margin and EPS, the uncertainty around physician reimbursement rates may continue to impact revenue growth and profitability in the near term.

INSP has been analyzed by 17 analysts, with a consensus rating of Buy. 12% of analysts recommend a Strong Buy, 35% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Buy based on their latest research and market trends.

According to 17 analysts, INSP has a Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $103.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $103.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.